Idamakanti, M. (2025) “Long Durable Response With Trastuzumab Deruxtecan Monotherapy in a Triple-Negative Metastatic Breast Cancer Patient With Human Epidermal Growth Factor Receptor 2 Mutation: A Long-Term Follow-Up and Literature Review”, Journal of Medical Cases, 16(6), pp. 212–221. doi:10.14740/jmc5136.